<DOC>
	<DOC>NCT02871297</DOC>
	<brief_summary>Evaluation of the long-term safety and tolerability of vortioxetine in child and adolescent patients with a Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5™) diagnosis of MDD</brief_summary>
	<brief_title>Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 18 Years of Age</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Vortioxetine</mesh_term>
	<criteria>The patient is a male or female child aged ≥7 and &lt;12 years or adolescent aged ≥12 and ≤18 years in the leadin study (12709A and 12710A). The patient must have completed Study 12709A or 12710A (Visit 12, Completion Visit) immediately prior to enrolment into this extension study. The patient had a primary diagnosis of MDD at entry in study 12709A or 12710A, diagnosed according to DSM5™. The patient is indicated for longterm treatment with vortioxetine according to the clinical opinion of the Investigator. For patients aged ≥7 and ≤17 years at the Baseline visit; the patient is able to understand the Informed Assent Form, and parent(s)/legal representative(s) are able to read and understand the Informed Consent Form. For patients who turned 18 years during the leadin study 12710A; the patient has signed the Informed Consent Form. The patient has been diagnosed with another psychiatric disorder (for example mania,bipolar disorder, schizophrenia or any psychotic disorder) during study 12709A or 12710A. The patient has an attentiondeficit/hyperactivity disorder (ADHD) that requires a pharmacological treatment other than a stimulant medication. Other protocoldefined inclusion and exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>adolescent</keyword>
	<keyword>children</keyword>
</DOC>